geranylgeraniol: Clinical Trials

4 trials of geranylgeraniol, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 recruiting, 1 unknown. 3 Not applicable, 1 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Not applicable3Completed 1, Recruiting 1, Unknown 1
Phase 21Completed 1
Phase 31Completed 1

Follow geranylgeraniol: new trials by email Literature Review of geranylgeraniol trials Research Report on geranylgeraniol

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Dose-Response Impact of Geranylgeraniol (GG) Supplementation on Muscle Health
Dietary Supplement - Placebo, Geranylgeraniol (150 mg), Geranylgeraniol (300 mg) - Muscle Health, Muscle Strength
Not applicableRecruitingLindenwood University702025-03-032026-03-31
A Crossover Clinical Trial Investigating the Effects of Geranylgeraniol (GG) Supplementation on Testosterone Levels in Healthy Men and Women Over an 18-week Period
Geranylgeraniol 300 mg, Placebo - Wellness, Health
Not applicableCompletedDesigns for Health342025-01-302026-05-01
Comparing the Effects of Commercially Available Dietary Supplements on CoQ10 Concentrations
Ubiquinol + geranylgeraniol, Geranylgeraniol, Ubiquinol - Wellness, Health
Phase 2 / Phase 3CompletedOvationLab1502024-10-122026-03-04
Geranylgeraniol Supplementation in Patients With Mevalonate Kinase Deficiency
geranylgeraniol - Mevalonate Kinase Deficiency
Not applicableUnknownUniversity Hospital, Motol62022-01-252024-07-12

Conditions studied

Mevalonate Kinase Deficiency (1)

Sponsors

Designs for Health (1)  ·  Lindenwood University (1)  ·  OvationLab (1)  ·  University Hospital, Motol (1)

Countries

United States (3)  ·  Czechia (1)

Top investigators

Chad M Kerksick, PhD (1)

Results publications

PMID 42807157